Patients with Bleeding Disorder Cautioned about WinRho SDF

By Elizabeth Rhein

Published on January 09, 2006

WinRho SDF is a highly specialized medication that is often prescribed to women who have given birth to babies with an incompatible Rh factor. It is designed to reduce the risk of the mother or baby contracting Rhesus disease, a condition that causes reduced levels of iron and red blood cells in the body.

Recent studies have shown that patients with the bleeding disorder immune thrombocytopenic purpura (ITP) should be extremely cautious when taking WinRho SDF, as these individuals may experience a potentially fatal loss of red blood cells. This adverse reaction usually occurs within four hours of receiving the medication.

Due to the FDA warning issued on the drug, the medication's makers have changed the labeling on the packaging. Patients with ITP are urged to contact their medical providers if they experience symptoms such as fever, shaking, back pain, chills, swelling, or shortness of breath. These symptoms could indicate a sudden loss of red blood cells.

If you are currently taking WinRho SDF, contact your physician with questions or concerns.

Comment on this article →